Martin Shkreli Faces New Accusations Over High-Priced Drug


By BY CECILIA KANG from NYT Business
https://ift.tt/37y7t0L
A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.
Share:

Related Posts:

No comments:

Post a Comment

Popular Posts

Blog Archive

Powered by Blogger.

Labels

Blog Archive